MannKind Corporation MNKD
4.13 USD -0.03 (-0.72%)
Regular-session close
4.13 0.00 0.00%
After hours · Nov 13, 4:01 PM ET
4.08 Day range 4.18
2.28 52-week range 6.21
- YTD
- -27.16%
- 1 year
- -18.54%
News
seekingalpha.com MannKind's ReadyFlow Launch Keeps The Bull Case Alive MNKD's ReadyFlow could widen Furoscix's reach into more outpatient settings, which I consider a promising value driver in the long run. Also, their pediatric launch expands Afrezza's market. The main…
benzinga.com RBC Capital Maintains Sector Perform on MannKind, Raises Price Target to $5 RBC Capital analyst Douglas Miehm maintains MannKind (NASDAQ:MNKD) with a Sector Perform and raises the price target from $4.75 to $5.- benzinga.com Cantor Fitzgerald Maintains Overweight on MannKind, Raises Price Target to $10 Cantor Fitzgerald analyst Olivia Brayer Saunders maintains MannKind (NASDAQ:MNKD) with a Overweight and raises the price target from $8 to $10.
benzinga.com Cantor Fitzgerald Reiterates Overweight on MannKind, Maintains $8 Price Target Cantor Fitzgerald analyst Olivia Brayer Saunders reiterates MannKind (NASDAQ:MNKD) with a Overweight and maintains $8 price target.
benzinga.com This MannKind Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday Analysts initiate coverage: RSI Equal-Weight ($22), NWCL Neutral, HDRN Buy.
benzinga.com Chardan Capital Initiates Coverage On MannKind with Buy Rating, Announces Price Target of $10 Chardan Capital analyst Andreas Argyrides initiates coverage on MannKind (NASDAQ:MNKD) with a Buy rating and announces Price Target of $10.